MARKET

ACST

ACST

Acasti Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.6840
-0.0930
-11.97%
After Hours: 0.6900 +0.006 +0.88% 16:43 01/21 EST
OPEN
0.7600
PREV CLOSE
0.7770
HIGH
0.7650
LOW
0.6800
VOLUME
4.87M
TURNOVER
--
52 WEEK HIGH
3.080
52 WEEK LOW
0.5100
MARKET CAP
58.49M
P/E (TTM)
-1.1712
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ACST and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ACST News

  • Why Amarin Stock Is Poised for a Healthy 2020
  • InvestorPlace.4d ago
  • AstraZeneca to End Phase III Study on Fish Oil Heart Drug
  • Zacks.01/14 14:46
  • The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug
  • Benzinga.01/14 12:55
  • The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug
  • Benzinga.01/14 12:55

More

Industry

Pharmaceuticals
-0.30%
Pharmaceuticals & Medical Research
-0.40%

Hot Stocks

Name
Price
%Change

About ACST

Acasti Pharma Inc is a Canada-based biopharmaceutical company. The Company is focused on the research, development and commercialization of prescription drugs using omega 3 fatty acids (OM3s) derived from krill oil. OM3s has clinical evidence of safety and efficacy in lowering triglycerides in patients with hypertriglyceridemia (HTG). The Company's drug candidate is CaPre, an OM3 phospholipid, which is being developed for the treatment of severe hypertriglyceridemia, a condition characterized by abnormally high levels of triglycerides in the bloodstream (over 500 mg/dL) (severe hypertriglyceridemia or severe HTG).
More

Webull offers Acasti Pharma Inc (ACST) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.